Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10–13 September 2024

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2024-11-12 DOI:10.1016/j.vaccine.2024.126519

Philipp Lambach , Sheetal Silal , Alyssa N. Sbarra , Mitsuki Koh , Rakesh Aggarwal , Habib Hasan Farooqui , Stefan Flasche , Alexandra B. Hogan , Sun-Young Kim , Kathy Leung , William J. Moss , Patrick K. Munywoki , Allison Portnoy , Meru Sheel , Xuan-Yi Wang

{"title":"Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10–13 September 2024","authors":"Philipp Lambach , Sheetal Silal , Alyssa N. Sbarra , Mitsuki Koh , Rakesh Aggarwal , Habib Hasan Farooqui , Stefan Flasche , Alexandra B. Hogan , Sun-Young Kim , Kathy Leung , William J. Moss , Patrick K. Munywoki , Allison Portnoy , Meru Sheel , Xuan-Yi Wang","doi":"10.1016/j.vaccine.2024.126519","DOIUrl":null,"url":null,"abstract":"<div><div>The Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) is the primary advisory body of the World Health Organization conducting independent reviews of immunization-related implementation research, with a primary focus on transmission and economic modeling analyses that estimate the value and impact of vaccines. From 10 to 13th September 2024, IVIR-AC convened virtually for its second of two semi-annual meetings to provide feedback and recommendations across six sessions including: pneumococcal vaccination strategies that rely on indirect protection; vaccine impact modeling for chikungunya; The Lancet Commission on strengthening the use of epidemiological modeling of emerging and pandemic infectious diseases; methods for immunization coverage estimation; setting immunization research priorities in the South-East Asian Region; and modeling evidence related to typhoid conjugate vaccine schedules. This report summarizes the sessions, proceedings, and recommendations from that meeting.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"43 ","pages":"Article 126519"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X24012015","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) is the primary advisory body of the World Health Organization conducting independent reviews of immunization-related implementation research, with a primary focus on transmission and economic modeling analyses that estimate the value and impact of vaccines. From 10 to 13th September 2024, IVIR-AC convened virtually for its second of two semi-annual meetings to provide feedback and recommendations across six sessions including: pneumococcal vaccination strategies that rely on indirect protection; vaccine impact modeling for chikungunya; The Lancet Commission on strengthening the use of epidemiological modeling of emerging and pandemic infectious diseases; methods for immunization coverage estimation; setting immunization research priorities in the South-East Asian Region; and modeling evidence related to typhoid conjugate vaccine schedules. This report summarizes the sessions, proceedings, and recommendations from that meeting.

查看原文本刊更多论文

世界卫生组织免疫接种和疫苗相关实施研究咨询委员会（IVIR-AC）会议报告，虚拟会议，2024 年 9 月 10-13 日。

免疫接种和疫苗相关实施研究咨询委员会（IVIR-AC）是世界卫生组织的主要咨询机构，负责对免疫接种相关实施研究进行独立审查，主要关注估计疫苗价值和影响的传播和经济模型分析。2024 年 9 月 10 日至 13 日，IVIR-AC 以虚拟方式召开了两次半年度会议中的第二次会议，在六次会议上提出了反馈意见和建议，包括：依赖间接保护的肺炎球菌疫苗接种策略；基孔肯雅病疫苗影响建模；柳叶刀委员会关于加强新发和大流行传染病流行病学建模的使用；免疫接种覆盖率估算方法；确定东南亚地区免疫接种研究的优先事项；以及与伤寒结合疫苗接种计划相关的建模证据。本报告概述了会议的各次会议、会议记录和建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.